Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub
Peer-Reviewed Evidence
HomeDrug RegistryComparePRINCIPEN 250 vs PRINCIPEN
Comparative Pharmacology

PRINCIPEN 250 vs PRINCIPEN Comparison

Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.

Clinical EssentialsPharmacokineticsSpecial PopulationsSafety & MonitoringPregnancy & LactationClinical Insights
Differential Analysis

PRINCIPEN '250' vs PRINCIPEN

Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.

View PRINCIPEN '250' Monograph View PRINCIPEN Monograph
PRINCIPEN '250'
Aminopenicillin Antibiotic
Category C
PRINCIPEN
Aminopenicillin Antibiotic
Category C
TL;DR — Key Differences
  • Half-life: PRINCIPEN '250' has a half-life of 1.0-1.5 hours in normal renal function; prolongation in renal impairment requires dose adjustment; PRINCIPEN has 0.5–1 hour; prolonged to 7–10 hours in renal impairment (creatinine clearance <10 m L/min)..
  • No direct drug-drug interaction has been documented between PRINCIPEN '250' and PRINCIPEN.
  • Pregnancy: PRINCIPEN '250' is rated Category C; PRINCIPEN is rated Category C.

Last clinically reviewed: July 2026 · OpiCalc Medical Review Team

Clinical Essentials

PRINCIPEN '250'
PRINCIPEN
Mechanism of Action
PRINCIPEN '250'

Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.

PRINCIPEN

Ampicillin, a beta-lactam antibiotic, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) and interfering with transpeptidation, leading to cell lysis.

Indications
PRINCIPEN '250'

Infections caused by susceptible strains of Gram-positive and Gram-negative bacteria, including respiratory tract infections, urinary tract infections, meningitis, septicemia, and endocarditis,Off-label: Prophylaxis for bacterial endocarditis in dental procedures, treatment of listeriosis

PRINCIPEN

Infections of the respiratory tract (e.g., sinusitis, bronchitis, pneumonia) caused by susceptible organisms,Infections of the genitourinary tract (e.g., urinary tract infections, gonorrhea) caused by susceptible organisms,Infections of the gastrointestinal tract (e.g., typhoid fever, shigellosis) caused by susceptible organisms,Meningitis caused by susceptible organisms (e.g., Listeria monocytogenes, Neisseria meningitidis),Endocarditis (e.g., enterococcal endocarditis) - in combination with an aminoglycoside,Septicemia caused by susceptible organisms,Prophylaxis of bacterial endocarditis in patients undergoing dental or surgical procedures (off-label in some guidelines)

Standard Dosing
PRINCIPEN '250'

250 mg orally every 6 hours

PRINCIPEN

250-500 mg orally every 6 hours or 500 mg intravenously every 6 hours for moderate infections; severe infections: 500 mg-1 g every 4-6 hours.

Direct Interaction
PRINCIPEN '250'
No Direct Interaction
PRINCIPEN
No Direct Interaction

Pharmacokinetics

PRINCIPEN '250'
PRINCIPEN
Half-Life
PRINCIPEN '250'

1.0-1.5 hours in normal renal function; prolongation in renal impairment requires dose adjustment

PRINCIPEN

0.5–1 hour; prolonged to 7–10 hours in renal impairment (creatinine clearance <10 m L/min).

Metabolism
PRINCIPEN '250'

Ampicillin is primarily excreted unchanged by the kidneys via glomerular filtration and tubular secretion. Some hepatic metabolism occurs, but it is minimal.

PRINCIPEN

Ampicillin is partially metabolized by hepatic hydrolysis to penicilloic acid; approximately 90% of an oral dose is excreted unchanged in urine via tubular secretion and glomerular filtration.

Excretion
PRINCIPEN '250'

Primarily renal (60-80% unchanged), with some biliary/fecal excretion (approximately 10-20%)

PRINCIPEN

Primarily renal (90–100% unchanged) via tubular secretion and glomerular filtration. Minor biliary excretion (<1%).

Protein Binding
PRINCIPEN '250'

20-25% bound to serum albumin

PRINCIPEN

60–80% bound to albumin.

VD (L/kg)
PRINCIPEN '250'

0.2-0.3 L/kg, indicating limited extravascular distribution

PRINCIPEN

0.3–0.5 L/kg; indicates limited extravascular distribution.

Bioavailability
PRINCIPEN '250'

Oral: 25-40% (acid-labile, food reduces absorption)

PRINCIPEN

Oral: 30–50% (variable due to gastric acid lability); IM: 70–85%.

Special Populations

PRINCIPEN '250'
PRINCIPEN
Renal Adjustments
PRINCIPEN '250'

Cr Cl 10-50 m L/min: 250 mg every 12-24 hours; Cr Cl <10 m L/min: 250 mg every 24-48 hours

PRINCIPEN

Cr Cl >50 m L/min: no adjustment; Cr Cl 10-50 m L/min: 250-500 mg every 6-8 hours; Cr Cl <10 m L/min: 250-500 mg every 12 hours; hemodialysis: 250-500 mg every 12 hours, give dose after dialysis.

Hepatic Adjustments
PRINCIPEN '250'

No dosage adjustment required for mild to moderate hepatic impairment. Severe impairment (Child-Pugh C): reduce dose by 50% or extend interval to every 12 hours

PRINCIPEN

No adjustment required for mild to moderate hepatic impairment; caution in severe hepatic disease due to potential for accumulation, but specific Child-Pugh adjustments not established.

Pediatric Dosing
PRINCIPEN '250'

Children >1 month: 12.5-25 mg/kg orally every 6 hours; maximum 4 g/day

PRINCIPEN

Neonates 0-7 days: 50-100 mg/kg/day IV divided every 12 hours; Infants 1-4 weeks: 75-150 mg/kg/day IV divided every 8 hours; Children >1 month: 25-50 mg/kg/day orally divided every 6 hours, or 100-200 mg/kg/day IV divided every 4-6 hours; maximum 12 g/day.

Geriatric Dosing
PRINCIPEN '250'

Monitor renal function; adjust dose based on Cr Cl as for adults with renal impairment. Avoid in elderly with Cr Cl <10 m L/min unless necessary.

PRINCIPEN

No specific dose adjustment required; consider age-related renal impairment and adjust based on renal function; monitor for electrolyte disturbances and neurotoxicity.

Safety & Monitoring

PRINCIPEN '250'
PRINCIPEN
Black Box Warnings
PRINCIPEN '250'
FDA Black Box Warning

No FDA black box warning.

PRINCIPEN
FDA Black Box Warning

None

Warnings/Precautions
PRINCIPEN '250'

Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have been reported; contraindicated in patients with penicillin allergy.,Clostridium difficile-associated diarrhea (CDAD) can occur and may range in severity from mild diarrhea to fatal colitis.,Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi; superinfection may occur.,Use with caution in patients with renal impairment; dosage adjustment may be necessary.,Cases of drug-induced hepatitis and cholestatic jaundice have been reported.

PRINCIPEN

Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have been reported; discontinue therapy if reaction occurs.,Clostridium difficile-associated diarrhea (CDAD) may occur, ranging in severity from mild diarrhea to fatal colitis.,Prolonged use may result in overgrowth of nonsusceptible organisms (e.g., Candida).,Use with caution in patients with renal impairment; dose adjustment may be necessary.,Use with caution in patients with history of allergies (e.g., asthma, hay fever, urticaria) due to increased risk of hypersensitivity.

Contraindications
PRINCIPEN '250'

History of allergic reaction to any penicillin,Infections caused by penicillinase-producing organisms

PRINCIPEN

Hypersensitivity to ampicillin or any other beta-lactam antibiotic (e.g., penicillins, cephalosporins),Infectious mononucleosis (high incidence of maculopapular rash)

Adverse Reactions
PRINCIPEN '250'
Data Pending
PRINCIPEN
Data Pending
Food Interactions
PRINCIPEN '250'

Food significantly reduces ampicillin absorption. Avoid taking with meals, dairy products, or acidic beverages (e.g., orange juice). Metal ions (calcium, iron, zinc) and antacids chelate ampicillin, reducing bioavailability. Alcohol does not directly interact but may increase risk of gastrointestinal upset.

PRINCIPEN

Food decreases absorption; take on an empty stomach. Avoid acidic beverages (e.g., citrus juices) which may degrade the drug. No specific dietary restrictions.

Pregnancy & Lactation

PRINCIPEN '250'
PRINCIPEN
Teratogenic Risk
PRINCIPEN '250'

FDA Pregnancy Category B. Animal studies show no fetal risk, but no adequate human studies in first trimester. No known teratogenicity; use during pregnancy only if clearly needed.

PRINCIPEN

FDA Pregnancy Category B. Animal studies have not revealed evidence of fetal harm. No adequate, well-controlled studies in pregnant women. However, penicillin-class antibiotics are generally considered low risk. First trimester: No documented teratogenicity. Second and third trimesters: No documented fetal adverse effects. Use only if clearly needed.

Lactation Summary
PRINCIPEN '250'

Ampicillin is excreted in breast milk in low concentrations. M/P ratio approximately 0.1-0.2. Considered compatible with breastfeeding by American Academy of Pediatrics; monitor infant for diarrhea and candidiasis.

PRINCIPEN

Ampicillin is excreted into human breast milk in low concentrations (M/P ratio approximately 0.2-0.3). The American Academy of Pediatrics considers ampicillin compatible with breastfeeding. Potential for alteration of infant gut flora and interference with culture results if febrile. Use caution in infants with known penicillin allergy.

Pregnancy Dosing
PRINCIPEN '250'

Increased plasma volume and renal clearance during pregnancy may reduce serum ampicillin concentrations. No routine dose adjustment recommended, but for serious infections, doses at the higher end of the usual range may be considered. Monitor therapeutic response.

PRINCIPEN

No clinically significant pharmacokinetic changes requiring dose adjustment in pregnancy. Standard adult dosing is appropriate. For severe infections, higher doses may be needed due to increased volume of distribution and renal clearance, but no specific dose adjustment is routinely recommended.

Maternal Safety Status
PRINCIPEN '250'
Category C
PRINCIPEN
Category C

Clinical Insights

PRINCIPEN '250'
PRINCIPEN
Clinical Pearls
PRINCIPEN '250'

Principen '250' (ampicillin) is a penicillinase-sensitive aminopenicillin with activity against Gram-positive cocci (except penicillinase-producing staphylococci) and some Gram-negative bacilli. Key pearls: (1) Administer on an empty stomach (1 hour before or 2 hours after meals) to enhance absorption; (2) Monitor for maculopapular rash, especially in patients with infectious mononucleosis or cytomegalovirus infection, where incidence approaches 70-100%; (3) Dose adjustment required in renal impairment (Cr Cl <30 m L/min); (4) Use caution in patients with history of hypersensitivity to penicillins or cephalosporins; (5) Not effective against penicillin-resistant Streptococcus pneumoniae; (6) Consider drug fever or serum sickness-like reactions as adverse effects.

PRINCIPEN

Principen (ampicillin) is a penicillinase-sensitive penicillin. For empiric coverage, consider local resistance patterns; many E. coli and H. influenzae isolates are resistant. Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Monitor for hypersensitivity reactions, especially in patients with penicillin allergy. Use with caution in mononucleosis due to high rash incidence.

Patient Counseling
PRINCIPEN '250'

Take this medication exactly as prescribed, at evenly spaced times, and finish the full course even if you feel better.,Take on an empty stomach, at least 1 hour before or 2 hours after meals, with a full glass of water.,Do not take with antacids, laxatives, or fruit juices, as they may reduce absorption.,Contact your doctor immediately if you develop a skin rash, hives, difficulty breathing, or swelling of the face, lips, or tongue.,Diarrhea is common; do not treat with anti-diarrhea medications without consulting your doctor, as it may indicate a more serious condition.,Inform your doctor if you are pregnant, breastfeeding, or have a history of kidney disease, asthma, or allergic reactions to any antibiotic.,This drug may reduce the effectiveness of oral contraceptives; use an additional barrier method during treatment.

PRINCIPEN

Take on an empty stomach, at least 1 hour before or 2 hours after meals.,Complete the full course even if you feel better.,Notify your doctor if you develop a rash, diarrhea, or difficulty breathing.,Do not take if you are allergic to penicillins or cephalosporins.,Store capsules and oral suspension at room temperature; discard unused suspension after 14 days.

Safety Verification

Known Interactions

PRINCIPEN '250' Risks

No interactions on record

PRINCIPEN Risks

No interactions on record

Compare Alternatives

Related Drug Comparisons

Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.

PRINCIPEN '250' vs PRINCIPEN '125'Aminopenicillin Antibiotic
PRINCIPEN vs PRINCIPEN '125'Aminopenicillin Antibiotic
PRINCIPEN '250' vs PRINCIPEN '500'Aminopenicillin Antibiotic
PRINCIPEN vs PRINCIPEN '500'Aminopenicillin Antibiotic
Clinical Q&A

Frequently Asked Questions

Common clinical questions about PRINCIPEN '250' vs PRINCIPEN, answered by our medical review team.

1. What is the main difference between PRINCIPEN '250' and PRINCIPEN?

PRINCIPEN '250' is a Aminopenicillin Antibiotic that works by Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.. PRINCIPEN is a Aminopenicillin Antibiotic that works by Ampicillin, a beta-lactam antibiotic, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) and interfering with transpeptidation, leading to cell lysis.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.

2. Which is stronger: PRINCIPEN '250' or PRINCIPEN?

Potency comparisons between PRINCIPEN '250' and PRINCIPEN depend on the specific clinical indication. These are both Aminopenicillin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.

3. What is the standard dosing for PRINCIPEN '250' vs PRINCIPEN?

The standard adult dose of PRINCIPEN '250' is: 250 mg orally every 6 hours. The standard adult dose of PRINCIPEN is: 250-500 mg orally every 6 hours or 500 mg intravenously every 6 hours for moderate infections; severe infections: 500 mg-1 g every 4-6 hours.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.

4. Can you take PRINCIPEN '250' and PRINCIPEN together?

No direct drug-drug interaction has been formally documented between PRINCIPEN '250' and PRINCIPEN in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.

5. Are PRINCIPEN '250' and PRINCIPEN safe during pregnancy?

The maternal-fetal safety profiles differ. PRINCIPEN '250' is classified as Category C. FDA Pregnancy Category B. Animal studies show no fetal risk, but no adequate human studies in first trimester. No known teratogenicity; use during pregnancy only if clearly needed.. PRINCIPEN is classified as Category C. FDA Pregnancy Category B. Animal studies have not revealed evidence of fetal harm. No adequate, well-controlled studies in pregnant women. However, penicillin-class antibiotics are. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.